Başgöze, SerdarŞen, OnurGüner, YeşimDuman, Mert ZihniKaraçalılar, MehmetDemirel, AylinBayram, MuhammedAydın, Ünal2023-07-072023-07-072023Başgöze, S., Şen, O., Güner, Y., Duman, M. Z., Karaçalılar, M., Demirel, A. ve diğerleri. (2023). The fate of patent stents in patients undergoing coronary artery bypass grafting. E Journal of Cardiovascular Medicine, 11(2), 60-69.2147-1924https://search.trdizin.gov.tr/tr/yayin/detay/1182817https://hdl.handle.net/11468/12221https://search.trdizin.gov.tr/yayin/detay/1182817Objectives: Bypassing a patently stented coronary artery has a risk of flow competition, and leaving it ungrafted has a high risk of stent restenosis. This study determines the fate of patently stented coronary arteries bypassed and left ungrafted. Materials and Methods: Patients undergoing isolated coronary artery bypass grafting (CABG) with previous percutaneous coronary intervention (PCI) were retrospectively scanned between January 1, 2015, and January 1, 2020. Patients undergoing surgery with a patently stented coronary artery were identified. Postoperative coronary angiography was performed in 52 of these patients. Results: There were 24 patients whose patently stented coronary artery was bypassed and 28 whose patently stented coronary artery was not bypassed. The median follow-up time was 49 months in the non-bypass group and 53.5 months in the bypass group. Twenty (71.4%) patently stented coronary arteries remained open in the non-bypass group, and 23 (95.8%) vessels were open in the bypass group (p=0.02). The estimated open rate of vessels was 56% in the non-bypass group and 95% in the bypass group at five years (log-rank p=0.01). Major adverse cardiac events were developed in 12 (42.8%) patients in the non-bypass group and 6 (25%) patients in the bypass group. Conclusion: Patients with an open stented vessel that was not bypassed during CABG have a risk of in-stent restenosis and major adverse cardiac events during the mid-and long-term periods. It may not be safe to leave patently stented coronary arteries ungrafted, particularly those with bare metal stents.eninfo:eu-repo/semantics/openAccessCoronary artery bypass graftingMajor adverse cardiac eventsCoronary stent and percutaneous coronary interventionThe fate of patent stents in patients undergoing coronary artery bypass graftingThe fate of patent stents in patients undergoing coronary artery bypass graftingArticle1126069118281710.32596/ejcm.galenos.2023.2023-01-03